CARDIEX LIMITED - Announcements

11.1%

3.2¢

Market Cap $17.60M

Technology Scientific & Technical Instruments

CardieX Limited is an Australia-based digital health technology company. The Company... CardieX Limited is an Australia-based digital health technology company. The Company develops and markets noninvasive patient monitoring technologies for assessing cardiovascular health. It specializes in the development of biomarkers and digital solutions for large-scale cardiovascular health disorders. Its solutions are designed to be deployed at point-of-care for arterial health screening, and as part of a remote patient monitoring regimen to extend care and enhance cardiovascular health outcomes. Its suite of products includes medical and home health devices and digital solutions for hypertension, cardiovascular disease, and other vascular health disorders all based on the Company’s SphygmoCor vascular biomarker technology. Its products include CONNEQT Pulse, SphygmoCor XCEL, and Oscar 2 Ambulatory Blood Pressure Monitor. CONNEQT Pulse measures both brachial and central blood pressures alongside a suite of vascular biomarkers to provide unparalleled insights into vascular health.More

Actinogen Medical (ASX:ACW) reaches 100th participant milestone in Alzheimer’s Disease Trial & confirms interim analysis timeline.

Announcements

Filter Results

All Price Sensitive Only

CDX	Appendix 4C - quarterly (revised)		31/01/11	188.49KB	Share
CDX	First half market update		31/01/11	23.02KB	Share
CDX	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/11	187.68KB	Share
CDX	Amended change of directors interest notice		24/12/10	80.36KB	Share
CDX	Share trading policy		23/12/10	55.4KB	Share
CDX	US$1.28 million new pharmaceutical contract	PRICE SENSITIVE	21/12/10	65.14KB	Share
CDX	US$250,000 new research sale	PRICE SENSITIVE	20/12/10	64.95KB	Share
CDX	Change of Director's Interest Notice x 3		16/12/10	50.1KB	Share
CDX	Top 20 securityholders		08/12/10	64.09KB	Share
CDX	Appendix 3B		08/12/10	166.64KB	Share
CDX	Change of Director's Interest Notice x 5		07/12/10	96.96KB	Share
CDX	US$1.1 million new pharmaceutical contract	PRICE SENSITIVE	06/12/10	65.24KB	Share
CDX	Appendix 3B		02/12/10	167.46KB	Share
CDX	Top 20 securityholders		02/12/10	64.08KB	Share
CDX	Rights Issue Successfully Completed		02/12/10	74.74KB	Share
CDX	Results of Meeting		24/11/10	17.44KB	Share
CDX	AGM presentation		23/11/10	282.53KB	Share
CDX	Notice of Despatch of Rights Issue Documents		08/11/10	51.03KB	Share
CDX	US Therapeutic Project Grant	PRICE SENSITIVE	04/11/10	65.53KB	Share
CDX	Appendix 4C - First Quarter Report	PRICE SENSITIVE	27/10/10	98.41KB	Share
CDX	Appendix 3B - Placement		26/10/10	164.09KB	Share
CDX	Rights Offer Booklet	PRICE SENSITIVE	22/10/10	548.09KB	Share
CDX	Cleansing Notice		22/10/10	35.55KB	Share
CDX	Notice of AGM		21/10/10	34.67KB	Share
CDX	Letter to optionholders - rights issue		21/10/10	47.19KB	Share
CDX	Appendix 3B - Rights Issue		21/10/10	167.99KB	Share
CDX	Letter to shareholders - rights issue		21/10/10	32.34KB	Share
CDX	Rights issue - amended timetable		21/10/10	63.7KB	Share
CDX	Placement and Rights Issue Presentation		20/10/10	336.31KB	Share
CDX	Capital Raise and Rights Issue	PRICE SENSITIVE	20/10/10	67.28KB	Share
CDX	Request for Trading Halt		18/10/10	80.01KB	Share
CDX	Trading Halt	PRICE SENSITIVE	18/10/10	34.79KB	Share
CDX	US$0.8 million new pharmaceutical contract	PRICE SENSITIVE	15/10/10	65.16KB	Share
CDX	Annual Report to shareholders		30/09/10	758.83KB	Share
CDX	FDA welcomes central blood pressure data in pharma trials		09/09/10	66.36KB	Share
CDX	Preliminary Final Report	PRICE SENSITIVE	19/08/10	1.31MB	Share
CDX	Sales growth returns in H2	PRICE SENSITIVE	28/07/10	39.77KB	Share
CDX	Appendix 4C - quarterly	PRICE SENSITIVE	28/07/10	98.15KB	Share
CDX	Second positive Medicare coverage ruling in Michigan	PRICE SENSITIVE	07/07/10	44.71KB	Share
CDX	US$1.77 million new pharmaceutical contract	PRICE SENSITIVE	07/07/10	65.86KB	Share
CDX	Positive Medicare coverage ruling for Michigan	PRICE SENSITIVE	26/05/10	73.24KB	Share
CDX	Mayo publication supports central blood pressure measurement	PRICE SENSITIVE	11/05/10	83.01KB	Share
CDX	New pharmaceutical contract	PRICE SENSITIVE	21/04/10	31.37KB	Share
CDX	Investor Presentation		19/04/10	1.2MB	Share
CDX	Appendix 4C - quarterly	PRICE SENSITIVE	15/04/10	124.17KB	Share
CDX	US$0.95 million new pharmaceutical contract	PRICE SENSITIVE	30/03/10	73.79KB	Share
CDX	Pharmaceutical study demonstrates importance of central BP	PRICE SENSITIVE	19/03/10	51.26KB	Share
CDX	AtCor Medical launches new platform for clinicians		16/03/10	73.99KB	Share
CDX	Half Yearly Report and Accounts	PRICE SENSITIVE	18/02/10	418.57KB	Share
CDX	SphygmoCor uncovers positive drug effects in pre-eclampsia	PRICE SENSITIVE	17/02/10	77.69KB	Share
CDX	Central BP and superior determinant of LV hypertrophy		02/02/10	74.57KB	Share
CDX	Appendix 4C - quarterly	PRICE SENSITIVE	28/01/10	124.31KB	Share
CDX	1st Half Market Update	PRICE SENSITIVE	28/01/10	73.43KB	Share
CDX	Appendix 3B		23/12/09	195.56KB	Share
CDX	Change of Director's Interest Notice x 4		02/11/09	79.99KB	Share
CDX	Cardiovascular event threshold identified	PRICE SENSITIVE	28/10/09	72.06KB	Share
CDX	Appendix 3B		28/10/09	195.49KB	Share
CDX	Results of 2009 AGM		22/10/09	37.79KB	Share
CDX	Chairman's address - 2009 AGM		21/10/09	35.06KB	Share
CDX	2009 AGM - CEO's Presentation		21/10/09	433.06KB	Share
CDX	Appendix 4C - quarterly	PRICE SENSITIVE	21/10/09	124.45KB	Share
CDX	Annual Report to shareholders		18/09/09	800.07KB	Share
CDX	Notice of Annual General Meeting/Proxy Form		18/09/09	401.93KB	Share
CDX	Preliminary Final and Annual Report to shareholders	PRICE SENSITIVE	20/08/09	510.52KB	Share
CDX	Appendix 4C - quarterly	PRICE SENSITIVE	23/07/09	124.65KB	Share
CDX	Record Financial Results		23/07/09	31.49KB	Share
CDX	70% sales growth in FY09 expected	PRICE SENSITIVE	19/05/09	68.96KB	Share
CDX	Appendix 4C - quarterly	PRICE SENSITIVE	23/04/09	124.88KB	Share
CDX	US$0.6 million new pharmaceutical trial contract	PRICE SENSITIVE	20/04/09	71.96KB	Share
CDX	SphygmoCor shows drug lowers blood pressure in pre-eclampsia	PRICE SENSITIVE	16/04/09	76.39KB	Share
CDX	US$0.8 million new pharmaceutical trial contracts	PRICE SENSITIVE	15/04/09	71.96KB	Share
CDX	Change of Director's Interest Notice		07/04/09	101.06KB	Share
CDX	New application for AtCor's SphygmoCor technology		31/03/09	74.89KB	Share
CDX	Investor presentation		10/03/09	303.52KB	Share
CDX	AtCor reports maiden profit for first half		19/02/09	73.68KB	Share
CDX	Half Yearly Report and Accounts	PRICE SENSITIVE	19/02/09	189.3KB	Share
CDX	US$0.86mill new pharmaceutical and biotech trial contracts	PRICE SENSITIVE	28/01/09	74.58KB	Share
CDX	H1 sales surge 76% - upgrades guidance for FY2009	PRICE SENSITIVE	21/01/09	73.68KB	Share
CDX	Appendix 4C - quarterly	PRICE SENSITIVE	21/01/09	124.89KB	Share
CDX	US$1.5m new pharmaceutical trials contracts	PRICE SENSITIVE	08/12/08	74.98KB	Share
CDX	Study reveals elevated CP pressure in African-American men		04/12/08	70.53KB	Share
CDX	Change of Director's Interest Notice		03/12/08	26.65KB	Share

CDX Appendix 4C - quarterly (revised)
31/01/11		188.49KB	Share
CDX First half market update
31/01/11		23.02KB	Share
CDX Appendix 4C - quarterly
31/01/11	PRICE SENSITIVE	187.68KB	Share
CDX Amended change of directors interest notice
24/12/10		80.36KB	Share
CDX Share trading policy
23/12/10		55.4KB	Share
CDX US$1.28 million new pharmaceutical contract
21/12/10	PRICE SENSITIVE	65.14KB	Share
CDX US$250,000 new research sale
20/12/10	PRICE SENSITIVE	64.95KB	Share
CDX Change of Director's Interest Notice x 3
16/12/10		50.1KB	Share
CDX Top 20 securityholders
08/12/10		64.09KB	Share
CDX Appendix 3B
08/12/10		166.64KB	Share
CDX Change of Director's Interest Notice x 5
07/12/10		96.96KB	Share
CDX US$1.1 million new pharmaceutical contract
06/12/10	PRICE SENSITIVE	65.24KB	Share
CDX Appendix 3B
02/12/10		167.46KB	Share
CDX Top 20 securityholders
02/12/10		64.08KB	Share
CDX Rights Issue Successfully Completed
02/12/10		74.74KB	Share
CDX Results of Meeting
24/11/10		17.44KB	Share
CDX AGM presentation
23/11/10		282.53KB	Share
CDX Notice of Despatch of Rights Issue Documents
08/11/10		51.03KB	Share
CDX US Therapeutic Project Grant
04/11/10	PRICE SENSITIVE	65.53KB	Share
CDX Appendix 4C - First Quarter Report
27/10/10	PRICE SENSITIVE	98.41KB	Share
CDX Appendix 3B - Placement
26/10/10		164.09KB	Share
CDX Rights Offer Booklet
22/10/10	PRICE SENSITIVE	548.09KB	Share
CDX Cleansing Notice
22/10/10		35.55KB	Share
CDX Notice of AGM
21/10/10		34.67KB	Share
CDX Letter to optionholders - rights issue
21/10/10		47.19KB	Share
CDX Appendix 3B - Rights Issue
21/10/10		167.99KB	Share
CDX Letter to shareholders - rights issue
21/10/10		32.34KB	Share
CDX Rights issue - amended timetable
21/10/10		63.7KB	Share
CDX Placement and Rights Issue Presentation
20/10/10		336.31KB	Share
CDX Capital Raise and Rights Issue
20/10/10	PRICE SENSITIVE	67.28KB	Share
CDX Request for Trading Halt
18/10/10		80.01KB	Share
CDX Trading Halt
18/10/10	PRICE SENSITIVE	34.79KB	Share
CDX US$0.8 million new pharmaceutical contract
15/10/10	PRICE SENSITIVE	65.16KB	Share
CDX Annual Report to shareholders
30/09/10		758.83KB	Share
CDX FDA welcomes central blood pressure data in pharma trials
09/09/10		66.36KB	Share
CDX Preliminary Final Report
19/08/10	PRICE SENSITIVE	1.31MB	Share
CDX Sales growth returns in H2
28/07/10	PRICE SENSITIVE	39.77KB	Share
CDX Appendix 4C - quarterly
28/07/10	PRICE SENSITIVE	98.15KB	Share
CDX Second positive Medicare coverage ruling in Michigan
07/07/10	PRICE SENSITIVE	44.71KB	Share
CDX US$1.77 million new pharmaceutical contract
07/07/10	PRICE SENSITIVE	65.86KB	Share
CDX Positive Medicare coverage ruling for Michigan
26/05/10	PRICE SENSITIVE	73.24KB	Share
CDX Mayo publication supports central blood pressure measurement
11/05/10	PRICE SENSITIVE	83.01KB	Share
CDX New pharmaceutical contract
21/04/10	PRICE SENSITIVE	31.37KB	Share
CDX Investor Presentation
19/04/10		1.2MB	Share
CDX Appendix 4C - quarterly
15/04/10	PRICE SENSITIVE	124.17KB	Share
CDX US$0.95 million new pharmaceutical contract
30/03/10	PRICE SENSITIVE	73.79KB	Share
CDX Pharmaceutical study demonstrates importance of central BP
19/03/10	PRICE SENSITIVE	51.26KB	Share
CDX AtCor Medical launches new platform for clinicians
16/03/10		73.99KB	Share
CDX Half Yearly Report and Accounts
18/02/10	PRICE SENSITIVE	418.57KB	Share
CDX SphygmoCor uncovers positive drug effects in pre-eclampsia
17/02/10	PRICE SENSITIVE	77.69KB	Share
CDX Central BP and superior determinant of LV hypertrophy
02/02/10		74.57KB	Share
CDX Appendix 4C - quarterly
28/01/10	PRICE SENSITIVE	124.31KB	Share
CDX 1st Half Market Update
28/01/10	PRICE SENSITIVE	73.43KB	Share
CDX Appendix 3B
23/12/09		195.56KB	Share
CDX Change of Director's Interest Notice x 4
02/11/09		79.99KB	Share
CDX Cardiovascular event threshold identified
28/10/09	PRICE SENSITIVE	72.06KB	Share
CDX Appendix 3B
28/10/09		195.49KB	Share
CDX Results of 2009 AGM
22/10/09		37.79KB	Share
CDX Chairman's address - 2009 AGM
21/10/09		35.06KB	Share
CDX 2009 AGM - CEO's Presentation
21/10/09		433.06KB	Share
CDX Appendix 4C - quarterly
21/10/09	PRICE SENSITIVE	124.45KB	Share
CDX Annual Report to shareholders
18/09/09		800.07KB	Share
CDX Notice of Annual General Meeting/Proxy Form
18/09/09		401.93KB	Share
CDX Preliminary Final and Annual Report to shareholders
20/08/09	PRICE SENSITIVE	510.52KB	Share
CDX Appendix 4C - quarterly
23/07/09	PRICE SENSITIVE	124.65KB	Share
CDX Record Financial Results
23/07/09		31.49KB	Share
CDX 70% sales growth in FY09 expected
19/05/09	PRICE SENSITIVE	68.96KB	Share
CDX Appendix 4C - quarterly
23/04/09	PRICE SENSITIVE	124.88KB	Share
CDX US$0.6 million new pharmaceutical trial contract
20/04/09	PRICE SENSITIVE	71.96KB	Share
CDX SphygmoCor shows drug lowers blood pressure in pre-eclampsia
16/04/09	PRICE SENSITIVE	76.39KB	Share
CDX US$0.8 million new pharmaceutical trial contracts
15/04/09	PRICE SENSITIVE	71.96KB	Share
CDX Change of Director's Interest Notice
07/04/09		101.06KB	Share
CDX New application for AtCor's SphygmoCor technology
31/03/09		74.89KB	Share
CDX Investor presentation
10/03/09		303.52KB	Share
CDX AtCor reports maiden profit for first half
19/02/09		73.68KB	Share
CDX Half Yearly Report and Accounts
19/02/09	PRICE SENSITIVE	189.3KB	Share
CDX US$0.86mill new pharmaceutical and biotech trial contracts
28/01/09	PRICE SENSITIVE	74.58KB	Share
CDX H1 sales surge 76% - upgrades guidance for FY2009
21/01/09	PRICE SENSITIVE	73.68KB	Share
CDX Appendix 4C - quarterly
21/01/09	PRICE SENSITIVE	124.89KB	Share
CDX US$1.5m new pharmaceutical trials contracts
08/12/08	PRICE SENSITIVE	74.98KB	Share
CDX Study reveals elevated CP pressure in African-American men
04/12/08		70.53KB	Share
CDX Change of Director's Interest Notice
03/12/08		26.65KB	Share

REFRESH

First 4 5 6 7 8

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.2¢		Change -0.004(11.1%)		Mkt cap ! $17.60M

Open	High	Low	Value	Volume
3.2¢	3.2¢	3.2¢	$6.593K	206.0K

Buyers (Bids)

No.	Vol.	Price($)
2	195000	3.1¢

Sellers (Offers)

Price($)	Vol.	No.
3.3¢	100000	1

View Market Depth

No.	Vol.	Price($)
2	195000	0.031
7	672138	0.030
1	75000	0.029
2	275000	0.028
2	325000	0.027

Price($)	Vol.	No.
0.033	100000	1
0.034	100000	1
0.036	71197	1
0.037	500000	1
0.038	580000	1

Last trade - 13.09pm 11/08/2025 (20 minute delay)

CDX (ASX) Chart

CARDIEX LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories